Tatva Chintan Pharma Chem: Tatva Chintan Pharma Chem Q3 profit drops 49% to Rs 11.6 crore despite higher topline, impacted by weak operating performance. The specialty chemical company has reported a 49% year-on-year decline in consolidated profit at Rs 11.6 crore for quarter ended December FY23, impacted by weak operating performance. Revenue at Rs 120.6 crore grew by 15% over a year-ago period and EBITDA fell by 25% YoY to Rs 17.9 crore for the quarter.

Moneycontrol Pro Panorama | Good tidings for Indian IT from Accenture's results
Dec 19, 2025 / 03:21 PM IST
For Moneycontrol's Pro Panorama December 19 edition: Growth strong but jobs lag behind, a look at India’s coal growth story, wha...
Read NowAre you a PRO subscriber? Sign In
Ad free Experience
Seamless navigation, faster responses.
Expert Perspective
Explore 230+ exclusive editorials every month
+
Uncover Insights from World-Renowned Experts and Journalists
Actionable Insights
40+ weekly investment ideas + 3 to 4 daily technical calls
Virtual Events
Exclusive Live Webinars for Expert Trading & Investment Strategies!
Newsletters
Stay ahead with daily and weekly insights
Unlock exclusive discounts